Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Oncology

Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35243

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

California

UPDATED

Duarte California 91010-0269

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Los Angeles California 90024

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Santa Monica California 90403

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

View More ▼

Santa Monica California 90403

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Colorado

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Florida

Jacksonville Florida 32224

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Georgia

UPDATED

Atlanta Georgia 30341

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa

Iowa City Iowa 52242

A clinical trial to evaluate treatments using Bevacizumab, Gemcitabine, docetaxel and valproic acid for patients

Iowa City Iowa

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Radiotherapy for the treatment of Soft Tissue Sarcoma

Kentucky

UPDATED

Louisville Kentucky 40202

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Maryland

Baltimore Maryland 21218

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Minnesota

Rochester Minnesota 55905

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Missouri

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Nebraska

UPDATED

Omaha Nebraska 68114

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

New Mexico

UPDATED

Albuquerque New Mexico 87102

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

New York

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Buffalo New York 92122

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

New York New York 10029

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

North Carolina

UPDATED

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Durham North Carolina 27710

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Ohio

UPDATED

Cincinnati Ohio 45242

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Oregon

UPDATED

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19106

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

South Carolina

UPDATED

Spartanburg South Carolina 29303

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Tennessee

UPDATED

Germantown Tennessee 38138

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Texas

Dallas Texas 75230

A clinical research study of TRC105 and Pazopanib for the treatment of Advanced Soft Tissue Sarcoma

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Gemcitabine and Pazopanib and Gemcitabine and Docetaxel for the treatment of Sarcoma

Utah

UPDATED

Salt Lake City Utah 84112

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Vermont

Burlington Vermont 05401

A Phase 1/Phase 2 clinical study for patients with Operable Soft Tissue Sarcoma

Virginia

UPDATED

Fairfax Virginia 22031

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Argentina

UPDATED

Buenos Aires 1025

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

La Rioja 5300

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Rosario S2002KDS

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Australia

UPDATED

Camperdown 2050

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Nedlands 6009

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Woolloongabba 4102

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Austria

UPDATED

Wien 1090

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

Belgium

UPDATED

Brussels 1200

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma

UPDATED

Ghent 9000

Patients are needed to participate in a clinical research study of Olaratumab (LY3012207), Doxorubicin and Placebo to evaluate Soft Tissue Sarcoma